Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

计划入组 9 人 · 首次发布于 2025 年 2 月 12 日

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

计划入组 12 人 · 首次发布于 2025 年 1 月 24 日

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

计划入组 18 人 · 首次发布于 2025 年 2 月 24 日

anti-CD19 CAR T cells

Anti-CD19-CAR-T Cells(Tongji Hospital)

Mister Car Wash

United States

STEM CELLS ARABIA

Jordan

Novel Anti-Infective Technologies, LLC

Point-of-Care CAR-T Manufacturing Achieves 15-Day Vein-to-Vein Time in Jordan Phase II Trial

CD19 CAR T-Cell Therapy Demonstrates Promising Activity in Richter Transformation Despite Modest Outcomes

Hyperpolarized NMR Reveals Real-Time Metabolic Dynamics in CAR T Cell Manufacturing